In the TME, overexpression of the PD-L1 on tumor cells and engagement with its receptor programmed cell death protein 1 (PD-1) causes T-cell exhaustion and results in decreased anti-tumor activity [6,7]. This evidence concerns the gene PDCD1 and neoplasm.